KalVista Prices Upsized Offering of $125.0 Million of 3.250% Convertible Senior Notes Due 2031
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameKalVista Pharmaceuticals, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









